<?xml version="1.0" ?>
<document id="29519717">
  <sentence id="29519717.s0" text="Mutations in positive regulation of transcription by RNA polymerase II and oxidative phosphorylation were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).">
    <entity charOffset="13-70" id="29519717.s0.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="75-100" id="29519717.s0.e1" ontology_id="GO_0006119" text="oxidative phosphorylation" type="GO"/>
    <entity charOffset="147-173" id="29519717.s0.e2" ontology_id="HP_0002180" text="neurodegenerative diseases" type="HP"/>
    <entity charOffset="240-263" id="29519717.s0.e3" ontology_id="HP_0002145" text="frontotemporal dementia" type="HP"/>
    <pair e1="29519717.s0.e0" e2="29519717.s0.e2" id="29519717.s0.p0" relation="true"/>
    <pair e1="29519717.s0.e0" e2="29519717.s0.e3" id="29519717.s0.p1" relation="true"/>
    <pair e1="29519717.s0.e1" e2="29519717.s0.e3" id="29519717.s0.p2" relation="true"/>
  </sentence>
  <sentence id="29519717.s1" text="None of the patients showed positive regulation of transcription by RNA polymerase II mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in oxidative phosphorylation.">
    <entity charOffset="28-85" id="29519717.s1.e0" ontology_id="GO_0045944" text="positive regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="107-115" id="29519717.s1.e1" ontology_id="HP_0003745" text="sporadic" type="HP"/>
    <entity charOffset="173-198" id="29519717.s1.e2" ontology_id="GO_0006119" text="oxidative phosphorylation" type="GO"/>
    <pair e1="29519717.s1.e0" e2="29519717.s1.e1" id="29519717.s1.p0" relation="true"/>
    <pair e1="29519717.s1.e1" e2="29519717.s1.e2" id="29519717.s1.p1" relation="true"/>
  </sentence>
</document>
